Home Industries Services Case Studies Blogs Custom Research Syndicate Services About Us Contact us
Home Industries Services Case Studies Blogs Custom Research Syndicate Services About Us Contact us

Bipolar Disorder Treatment Market Size By Drug Class (Antidepressant Drugs, Mood Stabilizers, Antipsychotic Drugs, Antianxiety and Others), By Mechanism of Action (Beta-Blockers, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressant Drugs and Others), Regions, Segmentation, and Projection till 2030

CAGR: 3.3%Current Market Size: USD 4.42 BillionFastest Growing Region: APAC

Largest Market: North AmericaProjection Time: 2023-2030Base Year: 2022

Global Bipolar Disorder Treatment Market- Market Overview:

The global bipolar disorder treatment market is expected to grow from USD 4.42 billion in 2022 to USD 5.7 billion by 2030, at a CAGR of 3.3% during the Projection period 2023-2030. The growth of this market is mainly driven owing to the rising government initiatives to spread awareness about the proper management of the bipolar disorder.

A chronic mood disorder known as bipolar disorder causes extreme mood swings, fluctuation in energy levels, and behaviour. The main signs of bipolar disorder include manic and hypomanic episodes and depressive episodes. In addition to medications, talk therapy, lifestyle changes, and other treatments, the condition can be managed. According to WHO, bipolar disorder is the 6th biggest contributor to the total number of disabled people in the world. To mitigate its serious consequences, modern medicine has developed therapeutic drugs for its treatment that are now available in drug stores as over-the-counter bipolar medication. An increasing number of regulatory authorities are issuing special designations to boost the market. In addition to rising expenditures on healthcare infrastructure development, growing adoption of sedentary lifestyles increased government initiatives to promote awareness in backward areas, and an upswing in strategic collaboration among market players, other factors are also contributing to the market's growth. It has been observed that when treatment medications are prescribed to pregnant women, some medications can cause serious secondary effects such as renal disappointment and teratogenic changes in the hatchlings. Additionally, a tremendous number of times, bipolar turmoil may be misdiagnosed as depressive symptoms or a behavioural condition, which can likewise cause a delay in the discovery and treatment of this psychological disorder.

Sample Request: - Global Bipolar Disorder Treatment Market

Market Dynamics:

Drivers:                          

  • Rising government initiatives

The bipolar disorder treatment market is witnessing immense growth as people are becoming more aware of the management of the disorder due to rising government initiatives to spread awareness about bipolar disorder. In addition to conducting research studies and developing new medications for bipolar disorder drug therapy, scientific organizations and medical institutions also actively participate in the treatment of the bipolar disorder.

Restraints:                                             

  • Side effects associated with bipolar disorder treatment medications

Bipolar disorder treatment medications are causing side effects that are hindering the market growth. As a result of increasing awareness among the general population regarding the ill effects of long-term bipolar disorder drug use, as well as increased patient demand for chemical-free bipolar disorder medications, the demand for treatment may be slow over the Projection period.

Opportunities:

  • Technological Advancements

Technological advancements in the bipolar disorder treatment market are proven to be a beneficial step in the market growth. Wearable devices which can keep a check on each and every movement of the body and behavioural change are helping patients.

Challenges:

  • Lack of trained medical professionals

There will be a major challenge to market growth in developing and underdeveloped economies due to a lack of skilled medical professionals and unfavourable reimbursement situations. The growth of the market will also be hindered by the high costs associated with research and development capabilities.

Segmentation Analysis:

The global bipolar disorder treatment market has been segmented based on drug class, mechanism of action, and region.

By Drug Class

The drug class segment includes antidepressant drugs, mood stabilizers, antipsychotic drugs, antianxiety and others. The antipsychotic drugs segment led the largest share of the bipolar disorder treatment market with a market share of around 29% in 2022. Bipolar disorder treatment market revenue was dominated by antipsychotic drugs. The drug is combined with selective serotonin reuptake inhibitors (SSRI) to form a blend and has been shown to have excellent outcomes, prompting more physicians to prescribe it. As a temporary treatment for bipolar disorder, antipsychotic drugs are used to control insane side effects like hallucinations, and mania symptoms.

By Mechanism of Action

The mechanism of the action segment includes beta-blockers, selective serotonin reuptake inhibitors, tricyclic antidepressant drugs and others. The selective serotonin reuptake inhibitors segment led the largest share of the bipolar disorder treatment market with a market share of around 31% in 2022. An important reason for depression is insufficient serotonin, one of the major reasons for SSRIs' helpful actions. SSRIs work by inhibiting serotonin reuptake and thereby developing serotonin action as a result. As a result of their fewer effects on adrenergic, cholinergic, and histaminergic receptors, SSRIs also have moderately fewer aftereffects than other drugs.

Global Bipolar Disorder Treatment Market- Sales Analysis.

The sale of bipolar disorder treatment expanded at a CAGR of 3.1% from 2016 to 2022.

Several factors are driving the market for bipolar disorder treatment, including an increasing prevalence and innovation that works with exact recognition of the mental state and mind of a patient. A decrease in the use of tricyclic antidepressants has been attributed, for example, to a higher number of secondary effects compared to different medications used to treat the disorder.

In addition to improving the market for bipolar disorder drugs and treatment, technological advancements make it easier to detect a patient's emotional and mental state, as well as collect physiological, behavioural, and environmental information effectively, with the help of wearable devices.

The introduction of online self-management tools for mental illnesses has also helped bipolar disorder sufferers to get treatment earlier and better adhere to their medication regimens.

Thus, owing to the aforementioned factors, the global bipolar disorder treatment market is expected to grow at a CAGR of 9.6% during the Projection period from 2023 to 2030.

By Regional Analysis:

The regions analyzed for the bipolar disorder treatment market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region dominated the bipolar disorder treatment market and held a 37.8% share of the market revenue in 2022.

  • The North American region witnessed a major share. As a result of the high level of anxiety, lack of rest, and pattern of substance abuse among the population, North America is expected to experience the highest growth in the bipolar disorder treatment market during the Projection period. As well as to support patients with bipolar disorder, government initiatives to promote mindfulness and support will boost the market growth.
  • Asia Pacific is anticipated to experience significant growth during the predicted period. Asia Pacific is expected to enrol a higher CAGR over the Projectioned period because mental problems are more prevalent here. Among the nations most affected by mental disorders like schizophrenia, bipolar disorder, and tension, India and China rank among the highest.

Global Bipolar Disorder Treatment Market - Country Analysis:

  • Germany

Germany's bipolar disorder treatment market size was valued at USD 0.33 billion in 2022 and is expected to reach USD 0.43 billion by 2030, at a CAGR of 3.4% from 2023 to 2030.

The growth of the bipolar disorder market is fueled by technological advancements that have been used to develop genetic research and further expand the market, growing awareness of the disorder, and mergers & acquisitions among drug manufacturers, propelling the market growth.

  • China

China’s bipolar disorder treatment market size was valued at USD 0.34 billion in 2022 and is expected to reach USD 0.45 billion by 2030, at a CAGR of 3.6% from 2023 to 2030.

In addition to increasing expenditure on healthcare infrastructure development, increased government initiatives to boost awareness in underserved areas, and an increase in strategic collaboration among market players, market growth is driven by these factors. Society's increasing acceptance of mental illness is another variable that could provide profitable growth potential for bipolar disorder treatment.

  • India

India's bipolar disorder treatment market size was valued at USD 0.26 billion in 2022 and is expected to reach USD 0.34 billion by 2030, at a CAGR of 3.5% from 2023 to 2030.

In India, as a result of a growing geriatric population, increasing knowledge of mental illness, and an increasing number of research and development activities, healthcare infrastructure expenditures are on the rise. Moreover, by conducting research studies and developing new drugs for bipolar disorder treatment, scientific organizations and medical institutions are also actively involved in treating bipolar disorder, which is boosting market growth.

Key Industry Players Analysis:  

To increase their market position in the global bipolar disorder treatment market business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.

  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited
  • Allergan plc
  • Pfizer Inc.
  • Janssen Pharmaceuticals
  • Minerva Neurosciences
  • Otsuka Holdings Co. Ltd.
  • Sumitomo Dainippon Pharma Co. Ltd.
  • Novartis AG

Latest Development:

  • In January 2022, Oligomannate, Green Valley's novel medication, got FDA endorsement on its IND application for the worldwide multi-focus stage II clinical trial.
  • In October 2021, Boryung Pharmaceutical acquired all local rights, including sales and licensing, for Lilly's Zyprexa, a treatment for bipolar disorder.

Report Metrics

Report Attribute 

Details

Study Period

2022-2030

Base year

2022

CAGR (%)

3.3%

Market Size

4.42 billion in 2022

Projection period

2023-2030

Projection unit

Value (USD)

Segments covered

By Drug Class, By Mechanism of Action, and By Region.

Report Scope

Revenue Projection, competitive landscape, company ranking, growth factors, and trends

Companies covered

GlaxoSmithKline plc, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Allergan plc, Pfizer Inc., Janssen Pharmaceuticals, Minerva Neurosciences, Otsuka Holdings Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., and Novartis AG.

By Drug Class

  • Antidepressant Drugs
  • Mood Stabilizers
  • Antipsychotic Drugs
  • Antianxiety
  • Others         

By Mechanism of Action

  • Beta-Blockers
  • Selective Serotonin Reuptake Inhibitors
  • Tricyclic Antidepressant Drugs
  • Others                        

Regional scope

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Scope of the Report

Global Bipolar Disorder Treatment Market by Drug Class:

  • Antidepressant Drugs
  • Mood Stabilizers
  • Antipsychotic Drugs
  • Antianxiety
  • Others

Global Bipolar Disorder Treatment Market by Mechanism of Action:

  • Beta-Blockers
  • Selective Serotonin Reuptake Inhibitors
  • Tricyclic Antidepressant Drugs
  • Others

Global Bipolar Disorder Treatment Market by Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
  • Asia-Pacific
    • Japan
    • China
    • India
    • Korea
    • Southeast Asia
  • South America
    • Brazil
    • Peru
  • Middle East and Africa
    • UAE
    • South Africa
    • Saudi Arabia

Frequently Asked Questions

What will be the expected market size of the bipolar disorder treatment market in 2030?

Global bipolar disorder treatment market is expected to reach USD 5.7 billion by 2030, at a CAGR of 3.3% from 2023 to 2030.

What are the driving factors of the bipolar disorder treatment market?

Technological advancements and rising government initiatives.

Which region will witness more growth in the bipolar disorder treatment market?

North American region will witness more growth in the bipolar disorder treatment market.

Which are the leading market players active in the bipolar disorder treatment market?

Leading players in the bipolar disorder treatment market are GlaxoSmithKline plc, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Allergan plc, Pfizer Inc., Janssen Pharmaceuticals, Minerva Neurosciences, Otsuka Holdings Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Novartis AG among others.